Journal
JOURNAL OF MEDICAL VIROLOGY
Volume 94, Issue 7, Pages 3223-3232Publisher
WILEY
DOI: 10.1002/jmv.27735
Keywords
cytokine assay; lung pathology; mice; mouse-adapted strains; SARS-CoV-2; spillover risk; variants of concern
Categories
Funding
- National Key Research and Development Projects of the Ministry of Science and Technology of China [2021YFC2301300]
- National Key Research and Development Project of China [2020YFC0842200, 2020YFA0707801, 2021YFC0863300]
- National Natural Science Foundation of China [82041044]
Ask authors/readers for more resources
This study systematically investigated the infectivity and pathogenicity of three SARS-CoV-2 variants (Alpha, Beta, and Delta) in mice and found that the Beta variant had the strongest infectivity and pathogenicity, while the Delta variant had weaker replication and pathogenic changes. These results highlight the risk of SARS-CoV-2 spillover from humans to mice and suggest that key amino acid mutations in mouse-adapted strains can be used as an early-warning indicator for predicting the risk of newly emerging SARS-CoV-2 variants.
SARS-CoV-2 has evolved into a panel of variants of concern (VOCs) and constituted a sustained threat to global health. The wildtype (WT) SARS-CoV-2 isolates fail to infect mice, while the Beta variant, one of the VOCs, has acquired the capability to infect standard laboratory mice, raising a spreading risk of SARS-CoV-2 from humans to mice. However, the infectivity and pathogenicity of other VOCs in mice remain not fully understood. In this study, we systematically investigated the infectivity and pathogenicity of three VOCs, Alpha, Beta, and Delta, in mice in comparison with two well-understood SARS-CoV-2 mouse-adapted strains, MASCp6 and MASCp36, sharing key mutations in the receptor-binding domain (RBD) with Alpha or Beta, respectively. Our results showed that the Beta variant had the strongest infectivity and pathogenicity among the three VOCs, while the Delta variant only caused limited replication and mild pathogenic changes in the mouse lung, which is much weaker than what the Alpha variant did. Meanwhile, Alpha showed comparable infectivity in lungs in comparison with MASCp6, and Beta only showed slightly lower infectivity in lungs when compared with MASCp36. These results indicated that all three VOCs have acquired the capability to infect mice, highlighting the ongoing spillover risk of SARS-CoV-2 from humans to mice during the continued evolution of SARS-CoV-2, and that the key amino acid mutations in the RBD of mouse-adapted strains may be referenced as an early-warning indicator for predicting the spillover risk of newly emerging SARS-CoV-2 variants.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available